Synaptics CEO asserts investors misread a $30 billion shortfall while ON stock drops 9%. CEO comments on shortfall misinterpretation may sway near-term SYNA sentiment without altering core operations.
| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | 5 | 3 | 3 | — | 5 | 4 | 2 | 4 | 5 | — |
| total | individual payouts | |
|---|---|---|
| 2024 | ‡‡‡ |
|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2018 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Cash | 934.30 | 876.90 | 452.50 | 442.50 |
| Receivables | 163.90 | 142.40 | 130.30 | 164.00 |
| Inventory | 137.20 | 114.00 | 139.50 | 156.40 |
| Other | 35.00 | — | — | — |
| 1,272.00 | 1,162.30 | 751.90 | 787.00 |
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Payables | 45.80 | 87.50 | 98.50 | 82.60 |
| ST’ Debt | 6.00 | 6.00 | — | 439.60 |
| Other | 145.00 | — | — | — |
| 260.10 | 277.20 | 270.90 | 701.30 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 292.50 | 302.50 | 294.20 | 308.00 |
1,197.20
|
| ’25 | 257.70 | 267.20 | 266.60 | 282.80 |
1,074.30
|
| ’24 | 237.70 | 237.00 | 237.30 | 247.40 |
959.40
|
| ’23 | 448.10 | 353.10 | 326.60 | 227.30 |
1,355.10
|
| ’22 | 372.70 | 420.50 | 470.10 | 476.40 |
1,739.70
|
| ’21 | 328.40 | 357.60 | 325.80 | 327.80 |
1,339.60
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 30.20 | 29.80 | 21.80 | 67.60 |
149.40
|
| ’25 | (11.40) | 22.80 | 73.40 | 57.20 |
142.00
|
| ’24 | 45.40 | 39.20 | (13.70) | 65.00 |
135.90
|
| ’23 | 78.50 | 50.00 | 108.50 | 94.50 |
331.50
|
| ’22 | 58.30 | 122.40 | 127.70 | 154.30 |
462.70
|
| ’21 | 6.50 | 71.40 | 136.40 | 104.90 |
319.20
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 18.00 | 18.20 | 9.90 | 55.30 |
101.40
|
| ’25 | (20.50) | 18.10 | 58.00 | 50.60 |
106.20
|
| ’24 | (91.30) | 28.80 | (22.70) | 53.50 |
(31.70)
|
| ’23 | 72.30 | 40.00 | 94.80 | 89.30 |
296.40
|
| ’22 | 53.60 | 113.90 | 169.90 | 120.10 |
457.50
|
| ’21 | 2.60 | 97.30 | 98.90 | 99.30 |
298.10
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | (0.53) | (0.38) | (0.21) | (11.53) |
(12.62)
|
| ’25 | (0.58) | 0.05 | (0.56) | (0.12) |
(1.22)
|
| ’24 | (1.43) | (0.23) | (0.46) | 5.22 |
3.16
|
| ’23 | 1.59 | 0.55 | 0.26 | (0.59) |
1.83
|
| ’22 | 0.99 | 1.71 | 1.59 | 2.04 |
6.33
|
| ’21 | (0.08) | 1.36 | 0.35 | 0.48 |
2.08
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 81.13 | 67.73 | 67.83 | 41.80 | 64.53 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 294.70 | 142.14 | 115.85 | 89.81 | 149.11 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,775 | 1,891 | 1,716 | 1,700 | 1,700 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.98 | 0.72 | 0.56 | 0.63 | 0.70 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,739.70 | 1,355.10 | 959.40 | 1,074.30 | 1,197.20 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 54.21% | 52.83% | 45.84% | 44.72% | 44.72% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 320.50 | 126.00 | (124.60) | (113.50) | (79.40) | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.42% | 9.30% | (12.99%) | (10.57%) | (6.63%) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 257.50 | 73.60 | 125.60 | (47.80) | (490.80) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 147.50 | 157.80 | 109.20 | 143.10 | 149.80 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 44.61 | 34.22 | 24.47 | 27.34 | 30.78 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 6.60 | 1.86 | 3.20 | (1.22) | (12.62) | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.86 | 8.37 | 3.47 | 3.61 | 3.84 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.13) | (0.89) | (4.28) | (0.91) | (1.23) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.73 | 7.48 | (0.81) | 2.70 | 2.61 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 32.47 | 31.40 | 37.42 | 35.49 | 23.89 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 39.00 | 39.60 | 39.20 | 39.30 | 38.90 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.00 | 46.40 | 27.33 | 0.00 | 0.00 | ‡‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.65 | 2.50 | 3.52 | 2.37 | 4.04 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.64 | 2.72 | 2.30 | 1.83 | 5.20 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.71 | 2.53 | 3.62 | 2.73 | 4.37 | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.29 | 11.55 | (109.47) | 28.67 | 57.19 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 462.70 | 331.50 | 135.90 | 142.00 | 149.40 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (5.20) | (35.10) | (167.60) | (35.80) | (48.00) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 457.50 | 296.40 | (31.70) | 106.20 | 101.40 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 940.00 | 1,011.90 | 885.10 | 481.00 | 85.70 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 981.70 | 978.00 | 972.90 | 834.80 | 837.30 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 105.70 | 43.70 | 96.00 | 382.30 | 394.80 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,266.40 | 1,243.40 | 1,466.80 | 1,394.90 | 929.50 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.13% | 2.69% | 4.62% | (1.77%) | (20.95%) | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.96% | 7.49% | (4.06%) | (3.31%) | (3.17%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23.06% | 5.87% | 9.27% | (3.34%) | (42.23%) | — | — | — |
ROE
|
Synaptics Incorporated (SYNA), a pioneer in touch controllers, displays, and edge AI processors, has endured revenue volatility peaking at $1.74 billion in fiscal 2022 before plunging 45% to $959 million in 2024 amid inventory corrections and softening demand. Trading at levels implying a mean analyst upside of 10% (high 38%, low -12%), the stock faces insider selling pressure (13 transactions totaling $2.74 million in 2025-2026, no buys) and near-term profitability headwinds, yet quantitative signals point to undervaluation with EV/Sales at 3.6x versus peers and a resilient balance sheet boasting $1.47 billion in equity and $885 million working capital.
Revenue per employee cratered 43% to $559,000 in 2024 from 2022 highs, while gross margins eroded to 45.8% and ROIC flipped to -4.1%, amplifying swings in a high-beta semiconductor cycle (r=0.85 revenue-headcount correlation). Analysts forecast a rebound—12% growth to $1.188 billion in 2025, accelerating to $1.458 billion by 2027—with revenue per share up 54% and Monte Carlo simulations (10,000 paths) estimating 55% odds of positive EPS by 2028 and 15-20% mean stock upside if ROIC exceeds 10%.
Short-term risks include negative FCF, projected losses through 2027, and China exposure (20% revenue), but upside catalysts like the Astra AI platform, automotive ramps, and potential partnerships could restore 45-50% margins and justify a growth premium. SYNA presents asymmetric mean-reversion potential for quants, warranting scrutiny of Q1 2026 earnings amid Fed cut tailwinds.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.